Initially, it was thought that differences in expression levels or in the genetic variation of the virus entry proteins ACE2 and TMPRSS2 may be host factors that contribute to population differences in COVID-19-induced olfactory dysfunction [11,12]. This evidence concerns the gene ACE2 and COVID-19.